Sutro Biopharma, Inc. STRO
NASDAQ · United States · Health Technology
$15.35-0.62 (-3.88%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -2.33 | -2.19 | -6.2% | $9.84M | -17.7% | -14.9%$25.04→$21.31 |
| Q1 2026 | 2026-05-14 | -2.94 | -2.32 | -26.7% | — | — | -1.6%$39.60→$38.97 |
| Q4 2025 | 2026-03-23 | -4.88 | -4.43 | -10.2% | — | — | +14.0%$20.68→$23.57 |
| Q4 2024 | 2025-03-13 | -6.33 | -9.55 | +33.7% | — | — | — |
| Q1 2024 | 2024-05-13 | -8.90 | -9.95 | +10.6% | — | — | — |
| Q4 2023 | 2024-03-25 | 4.98 | -8.41 | +159.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.